Tnf News

Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.

According to a link unearthed by Ben Cunningham , there is preliminary research that the effects of Alzheimers may be reversible Building on previous work by the same authors, published in BioMed Central's ...

Following the widespread media coverage regarding the NICE FAD on the sequencing of anti-TNF inhibitors, Roche want to reassure patients with rheumatoid arthritis and rheumatology health professionals that they ...

Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis , according to guidelines issued by the American College of ...

Patients with a crippling condition are to be denied a choice of treatment under guidance to be published by the Government's drug watchdog today.

Thousands of patients with rheumatoid arthritis will be denied drugs under a ruling by the Health Service's 'rationing' body.

Three rheumatoid arthritis drugs should not be given to patients on Britain's state-run health service when similar drugs have already failed, the country's healthcare cost-effectiveness body said on Monday.

A video accompanying the research, published in the open access journal BMC Neurology, documents rapid language improvement within minutes of using this new treatment.

People with rheumatoid arthritis are to have access to a particular class of drugs limited by a drugs watchdog, campaigners say.

Main Category: Immune System / Vaccines Also Included In: Cardiovascular / Cardiology ; Arthritis / Rheumatology Article Date: 20 Jul 2008 - 11:00 PDT Drugs that have helped treat millions of rheumatoid ...

We reviewed 25 cases of TB due to another TNF antagonist, etanercept, that were reported to the US Food and Drug Administration between November 1998 and March 2002.

Drugs that have helped treat millions of rheumatoid arthritis sufferers may hold the key to many more medical conditions, including atherosclerosis - a leading cause of heart disease - says the researcher who ...

Amgen Inc. 's Enbrel anti- inflammatory drug reduces the symptoms of rheumatoid arthritis when given with a standard therapy early in the disease, a study found.

National report - The ongoing Food and Drug Administration review of TNF-blocking biologic drugs is unlikely to have much impact on dermatologists' use of these drugs, physicians say.

Persistent infection by high risk HPV types is the main risk factor for development of cervical intraepithelial neoplasia and cervical cancer.

Spondyloarthropathy patients who receive anti-tumor necrosis factor therapy experience significant changes in body composition, according to a report in the May issue of The Journal of Rheumatology.

Main Category: Arthritis Also Included In: Clinical Trials / Drug Trials Article Date: 16 Jun 2008 - 1:00 PDT Results of the RADIATE study Tocilizumab plus methotrexate showed significant clinical improvements ...

The Stowers Institute's Rong Li Lab has discovered that a protein previously shown to have a role in inflammation may also have a role in the formation of cysts in Autosomal Dominant Polycystic Kidney Disease - ...

Researchers at the Stowers Institute for Medical Research have discovered a possible cause of and treatment for the formation of cysts in one of the most common life-threatening genetic dieases, autosomal ...

Main Category: Arthritis Also Included In: Clinical Trials / Drug Trials ; Bones / Orthopaedics Article Date: 14 Jun 2008 - 12:00 PDT New data1 presented at the European League Against Rheumatism annual meeting ...